Net Income - Calithera Biosciences Inc (F:2CB) - Alpha Spread
C

Calithera Biosciences Inc
F:2CB

Watchlist Manager
Calithera Biosciences Inc
F:2CB
Watchlist
Price: 3.86 EUR -2.53% Market Closed
Market Cap: 1m EUR
Have any thoughts about
Calithera Biosciences Inc?
Write Note

Calithera Biosciences Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Calithera Biosciences Inc
Net Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
C
Calithera Biosciences Inc
F:2CB
Net Income
-$39.7m
CAGR 3-Years
24%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income
$5.4B
CAGR 3-Years
-7%
CAGR 5-Years
5%
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Net Income
-$384m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Income
$3.1B
CAGR 3-Years
-18%
CAGR 5-Years
-17%
CAGR 10-Years
-5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income
-$489.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income
$4.3B
CAGR 3-Years
-11%
CAGR 5-Years
16%
CAGR 10-Years
27%

See Also

What is Calithera Biosciences Inc's Net Income?
Net Income
-39.7m USD

Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's Net Income amounts to -39.7m USD.

What is Calithera Biosciences Inc's Net Income growth rate?
Net Income CAGR 5Y
-7%

Over the last year, the Net Income growth was 66%. The average annual Net Income growth rates for Calithera Biosciences Inc have been 24% over the past three years , -7% over the past five years .

Back to Top